FDA Adverse Event Malfunction Summary report: N

EVIS EXERA III XENON LIGHT SOURCE

MDR report key: 10910493 · Received November 26, 2020

Report

Report Number
8010047-2020-09509
Event Type
Malfunction
Date Received
November 26, 2020
Date of Event
October 30, 2020
Report Date
January 20, 2021
Manufacturer
OLYMPUS MEDICAL SYSTEMS CORP.
Product Code
NWB
PMA / PMN Number
CLASS2-EXMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THIS SUPPLEMENTAL REPORT IS BEING SUBMITTED TO PROVIDE ADDITIONAL INFORMATION. THE DEVICE HAS NOT BEEN RETURNED TO OMSC BUT WAS RETURNED TO OLYMPUS AUSTRALIA & NEW ZEALAND (OAZ) FOR EVALUATION. OAZ INSPECTED THE DEVICE AND DUPLICATED THE REPORTED PHENOMENON. OAZ CONFIRMED THAT THE EXAMINATION LAMP HAD FAILURE AND REPLACED THE EXAMINATION LAMP. THE EXACT CAUSE OF THE REPORTED EVENT COULD NOT BE CONCLUSIVELY DETERMINED, HOWEVER THERE IS POSSIBILITY THAT THE REPORTED EVENT WAS CAUSED BY THE LIFE OF THE EXAMINATION LAMP, BASED ON THE INFORMATION THAT OAZ HAS REPLACED THE LAMP. DEVICE HISTORY RECORD (DHR) REVIEW INDICATES THAT THE PRODUCT WAS MANUFACTURED AND TESTED IN ACCORDANCE WITH ALL APPLICABLE PROCEDURES AND MET ALL FINAL PRODUCT RELEASE CRITERIA. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS REPORT WILL BE SUPPLEMENTED.

Additional Manufacturer Narrative · 1

THE DEVICE IN THIS REPORT HAS NOT BEEN RETURNED TO OMSC FOR EVALUATION. THE EXACT CAUSE OF THE REPORTED EVENT COULD NOT BE CONCLUSIVELY DETERMINED AT THIS TIME. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS REPORT WILL BE SUPPLEMENTED.

Description of Event or Problem · 1

OLYMPUS MEDICAL SYSTEMS CORP. (OMSC) WAS INFORMED THAT THE EXAMINATION LAMP OF THE DEVICE WAS NOT IGNITED. THERE WAS NO REPORT OF PATIENT INJURY ASSOCIATED WITH THE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1376539 EVIS EXERA III XENON LIGHT SOURCE XENON LIGHT SOURCE NWB OLYMPUS MEDICAL SYSTEMS CORP. CLV-190

Patients

Seq Age Sex Outcome Treatment
1